In this review we will focus on experimental evidence of potential molecular mechanisms that have been uncovered linking TBI to the development of two forms of dementia: AD (characteristic Aβ and tau pathology) and CTE (a tauopathy). The gene discussed is MAPT; the disease is dementia.